Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
clinical trials
inclisiran
life sciences
national blog main
national top stories
new york
new york blog main
new york top stories
pcsk9
2
×
regeneron pharmaceuticals
sanofi
alirocumab
alnylam pharmaceuticals
biotech
cholesterol
data
deals
evolocumab
fda
ldl
mark timney
mt sinai hospital
novartis
pcsk9 inhibitors
peter wijngaard
praluent
prashant vaishnava
repatha
rna interference
san francisco blog main
san francisco top stories
the medicines co.
the medicines company
What
cholesterol
drug
medco
2
×
medicines
aces
acquire
agreed
announced
big
billion
brings
cash
ceo
company
compound
deal
fda
flexible
inclisiran
key
lowering
meant
medicine
nasdaq
new
novartis
open
passed
poised
pricing
ready
taken
test
twice
wave
week
year
Language
unset
Current search:
pcsk9
×
medco
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
